212 results
8-K
EX-99.1
TXMD
TherapeuticsMD Inc
29 Mar 24
TherapeuticsMD Announces Full Year 2023 Financial Results
4:29pm
innovative products to support the lifespan of women from pregnancy prevention through menopause. In December 2022, the Company changed its business
8-K
EX-99.1
TXMD
TherapeuticsMD Inc
14 Nov 23
TherapeuticsMD Announces Third Quarter 2023 Financial Results
4:25pm
and commercializing innovative products to support the lifespan of women from pregnancy prevention through menopause. In December 2022, the Company changed its
8-K
EX-99.1
9ik btyeay
14 Aug 23
TherapeuticsMD Announces Second Quarter 2023 Financial Results
7:15am
8-K
EX-99.1
f8ofwxnz wm8d
15 May 23
TherapeuticsMD Announces First Quarter 2023 Financial Results
4:16pm
8-K
EX-99.1
xyoxhd0z 59s0chtril8
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-99.1
4fcfikkpf6
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-99.1
prgj8
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-99.1
7g2jqlqcz8122 nv4f6
12 Sep 22
TherapeuticsMD Appoints Dr. Brian Bernick and Mr. Mark Glickman as Interim Co-Chief Executive Officers
7:01am
8-K
EX-99.1
2xwmsfc p7jj8n8sl
15 Aug 22
TherapeuticsMD Announces Second Quarter 2022 Financial Results
7:15am
8-K
EX-99.1
40w7o9xo
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
SC 14D9/A
EX-99
bxa39ki8c5j ot0rini
13 Jul 22
Tender offer solicitation (amended)
7:53am
SC 14D9
dzvz7rvqr
10 Jun 22
Tender offer solicitation
6:51pm
SC TO-T
EX-99
0txypxqmj86bpovf
6 Jun 22
Third party tender offer statement
5:02pm